CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2022

Nov 23, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2022-11-22

Reporting Person: GRANDE ALICIA (VP, Treasurer and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-22	Common Stock, par value $0.001 per share	S	120000	$16.527	Disposed	27442	Direct

Footnotes

F1: Shares were sold for personal reasons and not as a result of any disagreement with the Company. Ms. Grande remains an officer of the Company.

F2: Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $16.34 to $16.63 per share.